Calcium regulation in the human myocardium affected by dilated cardiomyopathy: a structural basis for impaired

S S Margossian1, P A Anderson, P D Chantler

  • 1Department of Medicine and Biochemistry and Molecular Biology, Albany Medical College, NY, USA.

Insights

Idiopathic dilated cardiomyopathy (IDC) impairs heart calcium regulation due to myofilament protein damage. Restoring these proteins improves heart muscle function, suggesting therapeutic targets for IDC.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Heart Failure Pathophysiology

Background:

  • Idiopathic dilated cardiomyopathy (IDC) is characterized by impaired cardiac contractility.
  • The precise molecular mechanisms underlying calcium dysregulation in IDC remain incompletely understood.

Purpose of the Study:

  • To investigate the structural basis of impaired calcium regulation in human hearts with IDC.
  • To identify specific myofilament protein alterations contributing to contractile dysfunction in IDC.

Main Methods:

  • Myofibrillar MgATPase assays and Ca2+-binding assays were used to assess calcium sensitivity and regulation.
  • Gel electrophoresis and Western blotting were employed to analyze myofibrillar proteolysis and troponin T isoform expression.
  • cDNA sequencing was performed to rule out mutations in key calcium-binding proteins.

Main Results:

  • IDC myofibrils exhibited significantly reduced calcium sensitivity, evidenced by altered MgATPase activity.
  • Proteolysis of myosin light chain 2 (LC2), troponin T (TnT), and troponin I (TnI) was observed in IDC hearts.
  • No mutations were found in LC2 and troponin C (TnC), indicating calcium binding itself was unaffected.

Conclusions:

  • Proteolytic damage to myofilament proteins, particularly LC2, TnT, and TnI, is a key factor in impaired calcium regulation in IDC.
  • Restoration of native LC2 and TnT/TnI improved myofibrillar function, highlighting their therapeutic potential.
  • Troponin T isoform shifts may play a role in IDC pathogenesis, suggesting genetic or compensatory mechanisms.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...